Literature DB >> 12605278

Malignancy in giant cell tumor.

F Bertoni1, P Bacchini, E L Staals.   

Abstract

Malignant giant cell tumor is a confusing term that in the past has been used to describe different types of giant cell-rich tumors. We try to clarify this term in this report. We consider two types of malignancy in giant cell tumor of bone: "primary" when it arises in juxtaposition to a benign giant cell tumor and 'secondary' when it arises at the site of a previously treated giant cell tumor. Here we present a case of primary malignancy in giant cell tumor that was initially not recognized as a malignancy. On radiography and histology of frozen sections the lesion had the appearance of a conventional giant cell tumor of bone. After curettage, the permanent histology slides showed areas of highly malignant osteosarcoma juxtaposed to areas of benign giant cell tumor. The patient was treated with chemotherapy and wide resection of the tumor.

Entities:  

Mesh:

Year:  2002        PMID: 12605278     DOI: 10.1007/s00256-002-0550-8

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  6 in total

1.  miR-181c associates with tumor relapse of high grade osteosarcoma.

Authors:  Federica Mori; Andrea Sacconi; Valeria Canu; Federica Ganci; Mariangela Novello; Vincenzo Anelli; Renato Covello; Virginia Ferraresi; Paola Muti; Roberto Biagini; Giovanni Blandino; Sabrina Strano
Journal:  Oncotarget       Date:  2015-06-10

2.  Giant cell-rich osteosarcoma in long bones: clinical, radiological and pathological features.

Authors:  Cheng-Sheng Wang; Qi-Hua Yin; Jin-Sheng Liao; Jiang-Hua Lou; Xiao-Yi Ding; Yan-Bo Zhu
Journal:  Radiol Med       Date:  2013-05-27       Impact factor: 3.469

3.  A diagnosis of giant cell-rich tumour of bone is supported by p63 immunohistochemistry, when more than 50 % of cells is stained.

Authors:  André Maues De Paula; Alexandre Vasiljevic; Roch Giorgi; Anne Gomez-Brouchet; Sébastien Aubert; Xavier Leroy; Hélène Duval; Gonzague de Pinieux; Corinne Bouvier
Journal:  Virchows Arch       Date:  2014-08-07       Impact factor: 4.064

4.  Case report: two-step malignant transformation of a liposclerosing myxofibrous tumor of bone.

Authors:  Kirk Campbell; Felasfa Wodajo
Journal:  Clin Orthop Relat Res       Date:  2008-07-08       Impact factor: 4.176

5.  Spontaneous malignant transformation of conventional giant cell tumor.

Authors:  H J Grote; M Braun; T Kalinski; N Pomjanski; W Back; U Bleyl; A Böcking; A Roessner
Journal:  Skeletal Radiol       Date:  2004-01-29       Impact factor: 2.199

6.  Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population.

Authors:  Xiaolong Zhu; Runzhi Huang; Peng Hu; Penghui Yan; Suna Zhai; Jie Zhang; Junwei Zhuang; Huabin Yin; Tong Meng; Daoke Yang; Zongqiang Huang
Journal:  Med Sci Monit       Date:  2021-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.